Hospices Civils de Lyon, Department of Endocrinology Diabetes Nutrition, Lyon Sud Hospital, Université Claude-Bernard, Lyon 1, France.
Diabetes Metab. 2013 Apr;39(2):132-8. doi: 10.1016/j.diabet.2012.09.006. Epub 2012 Nov 22.
The International Association of Diabetes and Pregnancy Study Group (IADPSG) guidelines for gestational diabetes mellitus (GDM) diagnosis determines that fasting, 1-h and 2-h glucose values may contribute independently to adverse outcomes. However, given the different physiological bases of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), differences in pregnancy outcomes are to be expected. This study aimed to determine whether classification of GDM women according to glucose homoeostasis results in heterogeneity in maternal and/or fetal outcomes.
Of the 75 pregnant women included after a 75-g 2-h OGTT performed between weeks 24-32 of gestation as per WHO criteria, 55 were classified as GDM (16 with IFG and 39 with IGT) according to IADSPG criteria. Their anthropometric and metabolic characteristics were compared with those of non-GDM women with IFG or IGT. Maternal and neonatal outcomes were prospectively recorded for each group.
GDM women with IFG, including isolated IFG and combined IFG+IGT, were significantly heavier, had higher leptin values and were more frequently multiparous than GDM women with isolated IGT. HOMA-IR was significantly higher when fasting glucose was impaired. There were no significant differences in maternal outcomes according to metabolic status. In addition, large for gestational age (LGA) neonates were significantly seen more often in the IFG group. Fasting glucose was significantly associated with LGA independently of BMI and 2-h OGTT glucose. The>5.1mmol/L cut-off value for fasting glucose was highly predictive of delivery of LGA infants.
IFG in GDM women was associated with increases in BMI, fat mass and hepatic insulin resistance. Delivery of LGA neonates was more frequent when fasting glycaemia was increased during the third trimester of pregnancy, and was independent of BMI and 2-h OGTT glucose values.
国际妊娠合并糖尿病研究组织(IADPSG)的妊娠糖尿病(GDM)诊断指南认为,空腹、1 小时和 2 小时血糖值可能会独立导致不良结局。然而,鉴于空腹血糖受损(IFG)和葡萄糖耐量受损(IGT)的生理基础不同,妊娠结局的差异是可以预期的。本研究旨在确定根据血糖稳态结果对 GDM 妇女进行分类是否会导致母婴结局的异质性。
根据世界卫生组织标准,对 75 名在妊娠 24-32 周期间进行 75g 2 小时口服葡萄糖耐量试验的孕妇进行了研究,其中 55 名孕妇被 IADSPG 标准诊断为 GDM(16 名 IFG 和 39 名 IGT)。将她们的人体测量学和代谢特征与非 GDM 孕妇的 IFG 或 IGT 进行了比较。为每个组前瞻性地记录了母婴结局。
IFG 的 GDM 妇女,包括单纯 IFG 和 IFG+IGT 合并,体重明显增加,瘦素值更高,且多胎妊娠的发生率高于单纯 IGT 的 GDM 妇女。空腹血糖受损时 HOMA-IR 明显升高。根据代谢状态,母婴结局无显著差异。此外,IFG 组巨大儿(LGA)的发生率明显更高。空腹血糖与 LGA 独立于 BMI 和 2 小时 OGTT 血糖显著相关。空腹血糖>5.1mmol/L 切点值对预测 LGA 婴儿的分娩具有高度预测价值。
GDM 妇女的 IFG 与 BMI、脂肪量和肝胰岛素抵抗增加有关。当妊娠晚期空腹血糖升高时,LGA 新生儿的分娩更为频繁,且与 BMI 和 2 小时 OGTT 血糖值无关。